Option Care Health, Inc. (NASDAQ:OPCH) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET

Company Participants

Michael Shapiro - CFO & SVP

John Rademacher - CEO, President & Director

Conference Call Participants

Matthew Larew - William Blair

Lisa Gill - JPMorgan

David MacDonald - Truist Securities

Kieran Ryan - Deutsche Bank

Joanna Gajuk - Bank of America

Jamie Perse - Goldman Sachs

Michael Petusky - Barrington Research

Operator

Good day and thank you for standing by. Welcome to the Option Care Health Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to our speaker Mike Shapiro. Please go ahead. Mike Shapiro, please go ahead.

Michael Shapiro

Good morning. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance and industry and market conditions. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from our expectations.

We encourage you to review the information in today's press release as well as in our Form 10-K filed with the SEC regarding the specific risks and uncertainties. We do not undertake any duty to update any forward-looking statements except as required by law.

During the call, we will use non-GAAP financial measures when talking about the company's performance and financial condition. You can find additional information on these non-GAAP measures in this morning's press release posted on the Investor Relations portion of our website.

With that, I'll turn the call over to John Rademacher, Chief Executive Officer.

John Rademacher

Thanks Mike and good morning everyone. The quarter results reflect our continued strong execution in a very challenging operator environment. Overall, we are quite pleased with the progress we made in the third quarter, while delivering solid growth in revenue and earnings. Growing EBITDA earnings by nearly 10% year-over-year during a period of significantly disruption, demonstrates the strength of our team and the resilience of the platform.

The team responded to dynamic market conditions including repositioning by some market participants, a significant natural disaster, and escalating inflationary pressure to help ensure we are providing real solutions to our referral partners and setting the standard for patient care across the industry.